These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. Varela M; Real MI; Burrel M; Forner A; Sala M; Brunet M; Ayuso C; Castells L; Montañá X; Llovet JM; Bruix J J Hepatol; 2007 Mar; 46(3):474-81. PubMed ID: 17239480 [TBL] [Abstract][Full Text] [Related]
28. Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design. Burrel M; Reig M; Forner A; Barrufet M; de Lope CR; Tremosini S; Ayuso C; Llovet JM; Real MI; Bruix J J Hepatol; 2012 Jun; 56(6):1330-5. PubMed ID: 22314428 [TBL] [Abstract][Full Text] [Related]
29. Transarterial chemoembolization with epirubicin-eluting beads versus transarterial embolization before liver transplantation for hepatocellular carcinoma. Nicolini A; Martinetti L; Crespi S; Maggioni M; Sangiovanni A J Vasc Interv Radiol; 2010 Mar; 21(3):327-32. PubMed ID: 20097098 [TBL] [Abstract][Full Text] [Related]
30. Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia. Han KH; Kudo M; Ye SL; Choi JY; Poon RT; Seong J; Park JW; Ichida T; Chung JW; Chow P; Cheng AL Oncology; 2011; 81 Suppl 1():158-64. PubMed ID: 22212951 [TBL] [Abstract][Full Text] [Related]
31. Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: a randomized phase III trial. Okusaka T; Kasugai H; Shioyama Y; Tanaka K; Kudo M; Saisho H; Osaki Y; Sata M; Fujiyama S; Kumada T; Sato K; Yamamoto S; Hinotsu S; Sato T J Hepatol; 2009 Dec; 51(6):1030-6. PubMed ID: 19864035 [TBL] [Abstract][Full Text] [Related]
32. Transarterial chemoembolization, transarterial chemotherapy, and intra-arterial chemotherapy for hepatocellular carcinoma treatment. Tsochatzis EA; Germani G; Burroughs AK Semin Oncol; 2010 Apr; 37(2):89-93. PubMed ID: 20494700 [TBL] [Abstract][Full Text] [Related]
33. Loco-regional treatment of hepatocellular carcinoma in the era of molecular targeted therapies. Lencioni R Oncology; 2010 Jul; 78 Suppl 1():107-12. PubMed ID: 20616592 [TBL] [Abstract][Full Text] [Related]
34. Arterial therapies of colorectal cancer metastases to the liver. de Baere T; Deschamps F Abdom Imaging; 2011 Dec; 36(6):661-70. PubMed ID: 21681492 [TBL] [Abstract][Full Text] [Related]
35. Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival. Kirchhoff TD; Bleck JS; Dettmer A; Chavan A; Rosenthal H; Merkesdal S; Frericks B; Zender L; Malek NP; Greten TF; Kubicka S; Manns MP; Galanski M Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):259-66. PubMed ID: 17548248 [TBL] [Abstract][Full Text] [Related]
36. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]